【活动】BioSpark聊biotech news：2024年五月生物医药大事讨论

汇聚群英智慧，闪亮你我星光

Together, Spark Biomedicine!

各领域专家汇聚在BioSpark Monthly News论坛，交流过去一个月发生的生物医药领域大事件。

本月热点

TOPICS

1.  2024 ASCO updates and beyond
2.  Oncology:

• DLL3/CD3 BITE approval for the extensive-stage SCLC;
• Summit/Akeso’s PD-1/VEGF Ivonescimab vs. Keytruda in Phase 3 1L NSCLC;
• Arvinas’ ER degrader vepdegestrant plus Pfizer’s palbociclib in breast cancer;

3.  Autoimmune Diseases:

• J&J acquired Proteologix for $850M and paid Numab $1.25B for atopic dermatitis;
• Biogen to acquire HI-Bio for $1.8B;

• GSK’s anti-IL-5 depemokimab succeeded in phase 3 severe asthma; 

4.  Other Diseases & New Modalities:

• Merck to acquire EyeBio for its unique Norrik mimic program;
• Novo Nordisk’s Factor VIII mimetic bispecific antibody in phase 3 hemophilia A;
• News on JNJ neuroscience spinout Rapport;
• Positive clinic data from Dyne for myotonic dystrophy and Duchenne muscular dystroph.

活动详情

主题：Monthly biotech news discussion -May 2024 in review

时间：2024年06月08日 Sat 9:00 PM（EST）/ 2024年06月09日 周日 早上9:00 AM（北京时间）

地点：zoom meeting（扫描二维码获得zoom注册链接或点击文末“阅读原文”）

嘉宾：

Jimmy Wang(王俊), Assistant Professor @ New York University

(https://www.linkedin.com/in/jun-jimmy-wang-69a16a58/)

Yanran He(何嫣然), Investment Director @ Sinopharm-CICC

(https://www.linkedin.cn/injobs/in/yanranhe)

Ethan Xu(徐亦迅), VP of Bioinformatics @ Aspen Neuroscience

(http://linkedin.com/in/ethan-yixun-xu-2b915a4)

Stephen Yan(严顺飞), BD Search & Evaluation @ AstraZeneca 

(https://www.linkedin.com/in/shunfei-yan/)

Qinghong Yan(晏庆红), CSO @ Leverna Therapeutics 

(http://linkedin.com/in/qinghong-yan)

Leon 'Jun' TANG(唐钧), Founding Partner @ InScienceWeTrust BioAdvisory

(https://www.linkedin.com/in/leontangnyc/)

Lihua Yu(于利华), Chief Data Officer @ fogpharma 

(https://www.linkedin.com/in/lihua-yu-5b3337)

Yongjiang Hei(黑永疆),  Co-CEO @ Biocity Biopharma

( http://linkedin.com/in/yonghei)

Wenjun Wu(Armstrong,吴文君), Director @ HanKang Venture

(https://www.linkedin.com/in/文君-吴-14787b95/)

本期活动组织：Jun Wang

本月热点总结：Armstrong和monthly news嘉宾

活动直播伙伴

About us

BioSpark

BioSpark Group成立于2019年8月，是在美国麻省注册的非盈利机构。BioSpark致力于推动生命科学领域的高级人才交流，建立富有合作和互助精神的社群生态环境，实现学术和企业的跨界交流及思想碰撞，从而帮助华人科学家在世界生物医药领域提升领导力、开拓企业家精神及促进科学发现的商业转化。

BioSpark Group is a non-profit corporation registered in Massachusetts of the United States. The purpose of BioSpark Group is to establish a biotechnology ecosystem with a collaborative and supportive scholar network, promote leadership and entrepreneurship, and facilitate scientific translation.

Follow us on Twitter: 
https://twitter.com/BioSpark_Group

Follow us on LinkedIn: 
https://www.linkedin.com/company/biospark-group

BioSpark events Calendar: 
https://tinyurl.com/tcwy44t6

Email us: [e-mail]

合作或加入日常活动交流群，请添加小助手微信号：BioSpark-Group

 赞 助  机   构 

 战 略  合   作 

BioSpark Group致力于建立华人在生物医领域的生态系统和互助网络，立足于波士顿，我们在硅谷和中国与LEAP Initiative、Dahshu和医药笔记达成战略合作。

更多精彩，请关注BioSpark公众号